Dealing with diabetes: Carnitine palmitoyltransferases (CPT) are promising new targets for the treatment of diabetes. Here, derivatives of R‐aminocarnitine, with the quaternary ammonium moiety replaced by groups lacking a permanent cationic charge, were designed and evaluated in vitro and in vivo as L‐ CPT I inhibitors.
Derivatives of R-Aminocarnitine without Ammonium Moiety as Liver Carnitine Palmitoyltransferase I (L-CPT I) Inhibitors / Tassoni E; Conti R; Gallo G; Vincenti S; Mastrofrancesco L; Brunetti T; Cabri W; Giannessi F. - In: CHEMMEDCHEM. - ISSN 1860-7179. - ELETTRONICO. - 6:11(2011), pp. 1977-1980. [10.1002/cmdc.201100289]
Derivatives of R-Aminocarnitine without Ammonium Moiety as Liver Carnitine Palmitoyltransferase I (L-CPT I) Inhibitors
Cabri W;
2011
Abstract
Dealing with diabetes: Carnitine palmitoyltransferases (CPT) are promising new targets for the treatment of diabetes. Here, derivatives of R‐aminocarnitine, with the quaternary ammonium moiety replaced by groups lacking a permanent cationic charge, were designed and evaluated in vitro and in vivo as L‐ CPT I inhibitors.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
